Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × INDUSTRY × zimberelimab × Clear all

Phase

Status

Active not recruiting 9 Recruiting 8 Completed 6 Terminated 3 Unknown 1 Not yet recruiting 1

Sponsor Class

OTHER 2 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 1

Interventions

Injections 45 Cisplatin 44 Paclitaxel 43 Carboplatin 37 Docetaxel 33 Gemcitabine 32 Capecitabine 29 Drug Therapy 28 pembrolizumab 26 Bevacizumab 21 anlotinib 20 Fluorouracil 20 icotinib 19 Cyclophosphamide 19 Oxaliplatin 16 fludarabine 15 Pemetrexed 15 Irinotecan 14 Cetuximab 13 Leucovorin 12 apatinib 11 Temozolomide 11 Nivolumab 11 Fulvestrant 11 tesetaxel 10 Doxorubicin 10 Trastuzumab 9 Rituximab 9 130-nm albumin-bound paclitaxel 9 camrelizumab 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03972722 2019-06-05

CC

Guangzhou Gloria Biosciences Co., Ltd.

Phase 2 Unknown

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡